Frederick Vogt
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Frederick G.
Vogt has been with Iovance Biotherapeutics, Inc. since 2016 and has held the titles of President, CEO, Secretary, and Director since 2024.
Education history includes a doctorate from Temple University (Pennsylvania), a doctorate from The Pennsylvania State University, and an undergraduate degree from Ursinus College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2026 | 562.492 ( 0,13 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director Ejecutivo | 18/06/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ursinus College
Ursinus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.